Serum Vascular Endothelial Growth Factor and COX-2/5-LOX Inhibition in Advanced Non-small Cell Lung Cancer: Cancer and Leukemia Group B 150304
Year: 2011
Type: article
Source: Journal of Thoracic Oncology
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: National Cancer Institute
Awards: G10814802, G1365514645, G1391839138, WUMC Cancer and Leukemia Group B, G1486637521, G1689128559, G199746015, CANCER AND LEUKEMIA GROUP B, G220937036, G2223902704, G2296793909, G257334932, G260759372, Cancer and Leukemia Group B, G2647518335, Cancer and Leukemia Group B Statistical Center, University of Iowa CALGB Institutional Grant, G3255944410, Southeast Cancer Control Consortium, Inc, Cancer and Leukemia Group B CCOP Research Base, Cancer and Leukemia Group B, Cancer and Leukemia Group B, G3710026009, Cancer and Leukemia Group B: RPCI/SUNYAB, G4530377164, G4744150602, CANCER AND LEUKEMIA GROUP B, CANCER AND LEUKEMIA GROUP B, CANCER AND LEUKEMIA GROUP B, Cancer and Leukemia Group B, Delaware/Christiana Care Community Clinical Oncology Program, CANCER AND LEUKEMIA GROUP B, Cancer and Leukemia Group B, G6886639697, CANCER CENTER CALGB PARTICIPATION, G7035163513, Hematology-Oncology Associates of Central New York CCOP, CANCER AND LEUKEMIA GROUP B--MINNESOTA ONCOLOGY GROUP, Cancer and Leukemia Group B, Nevada Cancer Research foundation-Community Clinical Oncology Program, CANCER AND LEUKEMIA GROUP B, G877081928, G877907214, G926666752, G973482110, G979369470
OpenAlex ID: W2017976137
